효소결합면역흡착측정법(ELISA) 시장 규모, 점유율, 성장 분석 : 제품 유형별, 용도별, 기술별, 최종사용자별, 지역별-2026년부터 2033년까지 업계 예측

Global Enzyme-Linked Immunosorbent Assay Market size was valued at USD 2.52 Billion in 2024 and is poised to grow from USD 2.65 Billion in 2025 to USD 3.95 Billion by 2033, growing at a CAGR of 5.1% during the forecast period 2026-2033.

The global enzyme-linked immunosorbent assay (ELISA) market is witnessing robust growth driven by the increasing prevalence of chronic and infectious diseases, advancements in assay technology, and a broader range of applications in drug discovery and food safety. ELISA is renowned for its precision in quantifying antigens and antibodies in biological samples, making it a vital tool for timely diagnosis and treatment in the expanding realm of disease surveillance. The transition in healthcare from reactive to preventive approaches further enhances the appeal of ELISA for early disease detection. Moreover, its essential role in vaccine development and quality control solidifies its importance in pharmaceutical and research sectors. The market is also evolving with the integration of AI, machine learning, IoT, and blockchain technology, enhancing diagnostic efficiency and accuracy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enzyme-Linked Immunosorbent Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enzyme-Linked Immunosorbent Assay Market Segments Analysis

The global enzyme-linked immunosorbent assay market is segmented into product type, applications, technology, end users, and region. By product type, the market is categorized into kits, reagents, and instruments. Depending on application, it is classified into clinical diagnostics, research, veterinary, and others. Based on technology, it is divided into sandwich ELISA, indirect ELISA, competitive ELISA, and direct ELISA. Based on end user, it is categorized into hospitals, diagnostic laboratories, research institutes, and others. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Driver of the Global Enzyme-Linked Immunosorbent Assay Market

The rising prevalence of health challenges has led to a heightened demand for effective, scalable, and affordable diagnostic tools, significantly boosting the adoption of the Enzyme-Linked Immunosorbent Assay (ELISA). Healthcare facilities, diagnostic laboratories, and research institutions are turning to ELISA as an integral component of standard diagnostic processes, especially in scenarios that require high-throughput testing. This method facilitates early detection of disease progression and allows for ongoing monitoring and therapeutic evaluation, which are essential for managing both chronic and non-communicable diseases. Consequently, the reliance on ELISA continues to grow as a vital tool in modern healthcare.

Restraints in the Global Enzyme-Linked Immunosorbent Assay Market

The Global Enzyme-Linked Immunosorbent Assay (ELISA) market faces significant constraints due to the reliance on proprietary antibodies, enzyme conjugates, and specialized reagents, all of which demand costly production processes, stringent validation, and comprehensive quality control measures. Such financial burdens frequently transfer to end users, restricting access in resource-limited settings. Additionally, the intricacies involved in multiplexing ELISA tests necessitate meticulous optimization to manage issues like cross-reactivity, signal interference, and reagent compatibility. This complexity poses challenges for market growth, particularly in environments lacking advanced technical expertise, thereby limiting the overall reach and adoption of ELISA technologies.

Market Trends of the Global Enzyme-Linked Immunosorbent Assay Market

The Global Enzyme-Linked Immunosorbent Assay (ELISA) market is experiencing a notable trend toward the adoption of automated and high-throughput platforms. Laboratories and diagnostic centers are increasingly integrating these advanced technologies to enhance operational efficiency. Automated ELISA analyzers facilitate seamless processes from plate loading to result reporting, effectively minimizing human error and accelerating turnaround times. This trend is particularly significant in sectors such as pharmaceutical research and vaccine development, where the capacity to rapidly screen large volumes of samples is critical. As the demand for precision and efficiency grows, the market is poised for sustained growth driven by these innovative solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Enzyme-Linked Immunosorbent Assay Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Kits
• Reagents
• Instruments

Global Enzyme-Linked Immunosorbent Assay Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics
• Research
• Veterinary
• Others

Global Enzyme-Linked Immunosorbent Assay Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Sandwich ELISA
• Indirect ELISA
• Competitive ELISA
• Direct ELISA

Global Enzyme-Linked Immunosorbent Assay Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

Global Enzyme-Linked Immunosorbent Assay Market Size & CAGR (2026-2033)

• North America (Product Type, Application, Technology, End User)
  • US
  • Canada
• Europe (Product Type, Application, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R&D Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Life Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLegend, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations